Cargando…

Withdrawal Syndrome Following Discontinuation of 28 Antidepressants: Pharmacovigilance Analysis of 31,688 Reports from the WHO Spontaneous Reporting Database

INTRODUCTION: Evidence is lacking on withdrawal syndrome related to individual antidepressants and relevant risk factors for severe reactions. OBJECTIVE: To ascertain whether antidepressants are associated with an increased reporting of withdrawal syndrome as compared with other medications, and to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gastaldon, Chiara, Schoretsanitis, Georgios, Arzenton, Elena, Raschi, Emanuel, Papola, Davide, Ostuzzi, Giovanni, Moretti, Ugo, Seifritz, Erich, Kane, John M., Trifirò, Gianluca, Barbui, Corrado
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676852/ https://www.ncbi.nlm.nih.gov/pubmed/36400895 http://dx.doi.org/10.1007/s40264-022-01246-4

Ejemplares similares

Pharmacovigilance analysis of the Vigibase on antidepressants-related withdrawal syndrome in adults and adolescents
por: Gastaldon, C., et al.
Publicado: (2023)

Pharmacovigilance analysis of the Vigibase on neonatal withdrawal syndrome following in utero exposure to antidepressants
por: Gastaldon, C., et al.
Publicado: (2023)

Neonatal withdrawal syndrome following in utero exposure to antidepressants: a disproportionality analysis of VigiBase, the WHO spontaneous reporting database
por: Gastaldon, C., et al.
Publicado: (2023)

Esketamine clinical trials: reply to Maju et al.
por: Gastaldon, C., et al.
Publicado: (2020)

Esketamine for treatment resistant depression: a trick of smoke and mirrors?
por: Gastaldon, C., et al.
Publicado: (2019)

Calling for policy actions to increase access to long-acting antipsychotics in low-income and middle-income countries
por: Ostuzzi, Giovanni, et al.
Publicado: (2022)

Safety of psychotropic medications in people with COVID-19
por: Ostuzzi, G., et al.
Publicado: (2021)

Safety of esketamine nasal spray: Analysis of post-marketing reports submitted to the FDA adverse event reporting system in the first year on the market
por: Gastaldon, C., et al.
Publicado: (2021)

Essential medicines for mental disorders: comparison of 121 national lists with WHO recommendations
por: Todesco, Beatrice, et al.
Publicado: (2023)

Clinical trajectories of individuals with severe mental illness continuing and discontinuing long-acting antipsychotics: a one-year mirror-image analysis from the STAR Network Depot study
por: Ostuzzi, Giovanni, et al.
Publicado: (2023)

Conversations with clients about antidepressant withdrawal and discontinuation
por: Karter, Justin M.
Publicado: (2020)

Pharmacological treatment of hyperactive delirium in people with COVID-19: rethinking conventional approaches
por: Ostuzzi, Giovanni, et al.
Publicado: (2020)

Which psychotherapy is effective in panic disorder? Findings and reflections from a systematic network meta-analysis
por: Papola, D., et al.
Publicado: (2021)

Poor implementation of the EU clinical trial regulation is a major threat for pragmatic trials in European countries
por: Ostuzzi, Giovanni, et al.
Publicado: (2020)

Predicting relapse after antidepressant withdrawal – a systematic review
por: Berwian, I. M., et al.
Publicado: (2017)

Which psychotherapy is effective in panic disorder? And which delivery formats are supported by the evidence? Study protocol for two systematic reviews and network meta-analyses
por: Papola, Davide, et al.
Publicado: (2020)

Tricyclic Antidepressant Withdrawal - A Case Report
por: Rajendra, P.N., et al.
Publicado: (1987)

Antidepressant-withdrawal mania - a case report
por: Magalhães, M., et al.
Publicado: (2021)

CBT treatment delivery formats for panic disorder: a systematic review and network meta-analysis of randomised controlled trials
por: Papola, Davide, et al.
Publicado: (2023)

Psychological and social interventions for the prevention of mental disorders in people living in low‐ and middle‐income countries affected by humanitarian crises
por: Papola, Davide, et al.
Publicado: (2020)

MON-688 Emphysematous Gastritis and Diabetes
por: Singh, Abhilasha, et al.
Publicado: (2020)

Correction to: Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations
por: Ostuzzi, Giovanni, et al.
Publicado: (2020)

Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations
por: Ostuzzi, Giovanni, et al.
Publicado: (2020)

The relationship between resting-state functional connectivity, antidepressant discontinuation and depression relapse
por: Berwian, Isabel M., et al.
Publicado: (2020)

Clozapine discontinuation withdrawal symptoms in schizophrenia
por: Blackman, Graham, et al.
Publicado: (2021)

SUN-688 Pancreatic Cancer in Longstanding Diabetes
por: Suarez, Janine
Publicado: (2020)

Focus on Clozapine Withdrawal- and Misuse-Related Cases as Reported to the European Medicines Agency (EMA) Pharmacovigilance Database
por: Chiappini, Stefania, et al.
Publicado: (2020)

Pharmacovigilance in perspective: drug withdrawals, data mining and policy implications
por: Alomar, Muaed, et al.
Publicado: (2019)

Antidepressant withdrawal – the tide is finally turning
por: Hengartner, Michael P., et al.
Publicado: (2019)

Low predictive power of clinical features for relapse prediction after antidepressant discontinuation in a naturalistic setting
por: Berwian, Isabel M., et al.
Publicado: (2022)

Antidepressant discontinuation in treatment resistant depression
por: Ali, Ziad A., et al.
Publicado: (2019)

Predictors of successful discontinuation of antipsychotics and antidepressants
por: Lincoln, Tania M., et al.
Publicado: (2023)

An assessment of the reporting of tapering methods in antidepressant discontinuation trials using the TIDieR checklist
por: McGoldrick, Amy, et al.
Publicado: (2023)

Cyclin-dependent kinase 4/6 inhibitors and interstitial lung disease in the FDA adverse event reporting system: a pharmacovigilance assessment
por: Raschi, Emanuel, et al.
Publicado: (2020)

Psychotherapies for Generalized Anxiety Disorder in Adults: A Systematic Review and Network Meta-Analysis of Randomized Clinical Trials
por: Papola, Davide, et al.
Publicado: (2023)

Liver Injury with Nintedanib: A Pharmacovigilance–Pharmacokinetic Appraisal
por: Raschi, Emanuel, et al.
Publicado: (2022)

Challenges of the pharmacological management of benzodiazepine withdrawal, dependence, and discontinuation
por: Fluyau, Dimy, et al.
Publicado: (2018)

Direct Oral Anticoagulants and Interstitial Lung Disease: Emerging Clues from Pharmacovigilance
por: Raschi, Emanuel, et al.
Publicado: (2020)

Exam Ref 70-688 : configuring Windows 8.1
por: Ballew, Joli
Publicado: (2014)

POS-688 COVID19 INFECTION IN KIDNEY TRANSPLANT RECIPIENTS
por: ALAOUI MDAGHRI, A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_o2bage0mpe0ggblef8ndkotnj0